Brief: Cellect Biotechnology Reports Q1 Loss Per Share Of $0.002

Quoin Pharmaceuticals

21/05/2020 21:04

May 21 (Reuters) - Cellect Biotechnology Ltd  APOP.O :
    * CELLECT BIOTECHNOLOGY REPORTS FIRST QUARTER 2020 FINANCIAL
AND
OPERATING RESULTS; CONTINUES TO DEMONSTRATE SIGNIFICANT PROGRESS
DESPITE ADJUSTED OPERATIONS DUE TO COVID-19
    * Q1 LOSS PER SHARE $0.002
    * COMPANY'S CASH AND CASH EQUIVALENTS TOTALED $7.08 MILLION
AS OF
MARCH 31, 2020

Source text for Eikon:  ID:nGNX7g9S2S 
Further company coverage:  APOP.O 

 ((Reuters.Briefs@thomsonreuters.com;))